Personalised radiation therapy taking both the tumour and patient into consideration
Authors
Overgaard, J.Aznar, M. C.
Bacchus, C.
Coppes, R. P.
Deutsch, E.
Georg, D.
Haustermans, K.
Hoskin, P.
Krause, M.
Lartigau, E. F.
Lee, A. W. M.
Löck, S.
Offersen, B. V.
Thwaites, D. I.
van der Kogel, A. J.
van der Heide, U. A.
Valentini, V.
Baumann, M.
Affiliation
Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark. Electronic address: jens@oncology.au.dk. Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, The Christie NHS Foundation Trust, United Kingdom. German Cancer Research Center (DKFZ), Heidelberg, Germany. Departments of Radiation Oncology and Biomedical Sciences of Cells & Systems, Section Molecular Cell Biology, University of Groningen, University Medical Center Groningen, the Netherlands. Department of Radiation Oncology, Institut d'Oncologie Thoracique (IOT), Gustave Roussy, France. Division Medical Radiation Physics, Department of Radiation Oncology, Medical University of Vienna/AKH Wien, Austria. Department of Radiation Oncology, University Hospitals Leuven, Belgium. Mount Vernon Cancer Centre and University of Manchester, United Kingdom. Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany. Academic Department of Radiotherapy, Oscar Lambret Comprehensive Cancer Center, Lille, France. Department of Clinical Oncology, University of Hong Kong - Shenzhen Hospital and University of Hong Kong, China. OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Germany. Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark. Institute of Medical Physics, School of Physics, The University of Sydney, Australia; Medical Physics Group, Leeds Institute of Medical Research, School of Medicine, University of Leeds, United Kingdom. Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, USA. Department of Radiation Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands. Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, UOC Radioterapia Oncologica, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.Issue Date
2022
Metadata
Show full item recordCitation
Overgaard J, Aznar MC, Bacchus C, Coppes RP, Deutsch E, Georg D, et al. Personalised radiation therapy taking both the tumour and patient into consideration. Vol. 166, Radiotherapy and Oncology. Elsevier BV; 2022. p. A1–5.Journal
Radiother OncolDOI
10.1016/j.radonc.2022.01.010PubMed ID
35051440Additional Links
https://dx.doi.org/10.1016/j.radonc.2022.01.010Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.radonc.2022.01.010
Scopus Count
Collections
Related articles
- Gender-dependent radiotherapy: The next step in personalised medicine?
- Authors: De Courcy L, Bezak E, Marcu LG
- Issue date: 2020 Mar
- The Promise and the Hype of 'Personalised Medicine'.
- Authors: Maughan T
- Issue date: 2017 Apr
- MicroRNA in radiotherapy: miRage or miRador?
- Authors: Korpela E, Vesprini D, Liu SK
- Issue date: 2015 Mar 3
- Personalised medicine in veterinary oncology: one to cure just one.
- Authors: Klopfleisch R
- Issue date: 2015 Aug
- Cancer Precision Medicine: Why More Is More and DNA Is Not Enough.
- Authors: Schütte M, Ogilvie LA, Rieke DT, Lange BMH, Yaspo ML, Lehrach H
- Issue date: 2017